Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction "CHARM"

Not yet recruiting

Phase 3 Results N/A

References

Sources for Trial Information